Skip to main content
See every side of every news story
Published loading...Updated

These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?

Summary by The Motley Fool
Key PointsWeight loss candidates from Amgen and Roche performed well in phase 2 studies.These could be exciting additions to these companies' drug portfolios.Both drugmakers have attractive lineups and deep pipelines beyond this area. 10 stocks we like better than Amgen › During the first half of 2025, Wegovy and Zepbound, two weight loss drugs, ranked among the top 10 best-selling medicines worldwide. And given current projections for this mark…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Thursday, February 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal